Publication Name	World Journal of Clinical Cases
Manuscript ID	86183
Country	China

Received	2023-06-06 12:10
Peer-Review Started	2023-06-06 12:11
To Make the First Decision
Return for Revision	2023-08-08 03:29
Revised	2023-08-22 09:43
Second Decision	2023-08-31 02:48
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-08-31 07:49
Articles in Press	2023-08-31 07:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-09-07 23:59
Publish the Manuscript Online	2023-09-20 16:48

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Triplet regimen as a novel modality for advanced unresectable hepatocellular carcinoma: A case report and review of literature
Manuscript Source	Unsolicited Manuscript
All Author List	Ying Zhao, Guo-Sheng He and Gong Li
ORCID	Author(s) ORCID Number Gong Li http://orcid.org/0000-0002-6437-7785
Funding Agency and Grant Number
Corresponding Author	Gong Li, MD, Doctor, Researcher, Department of Radiation Oncology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, No. 168 Litang Road, Changping District, Beijing 102218, China. dr_gongli@163.com
Key Words	Hepatocellular carcinoma; Portal vein tumor thrombosis; Radiotherapy; Combination therapy; RACIB; Case report
Core Tip	Primary hepatoma patients with inferior vena cava tumor thrombus and portal vein tumor thrombus are rare, and both are inferior prognostic factors for such patients. There are no worldwide consensuses or guidelines on the diagnosis and treatment of hepatocellular carcinoma patients with macrovascular invasion. We used a new treatment model for this patient: radiotherapy combined with target therapy followed by immune maintenance therapy; and achieved extended survival.
Publish Date	2023-09-20 16:48
Citation	Zhao Y, He GS, Li G. Triplet regimen as a novel modality for advanced unresectable hepatocellular carcinoma: A case report and review of literature. World J Clin Cases 2023; 11(27): 6558-6564
URL	https://www.wjgnet.com/2307-8960/full/v11/i27/6558.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i27.6558

Full Article (PDF)	WJCC-11-6558-with-cover.pdf
Full Article (Word)	WJCC-11-6558.docx
CARE Checklist–2016	86183-CARE Checklist (2016).pdf
Manuscript File	86183_Auto_Edited-LJH-JLW.docx
Answering Reviewers	86183-Answering reviewers.pdf
Audio Core Tip	86183-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	86183-Conflict-of-interest statement.pdf
Copyright License Agreement	86183-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	86183-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	86183-Language certificate.pdf
Peer-review Report	86183-Peer-review(s).pdf
Scientific Misconduct Check	86183-Bing-Liu JH-2.png
Scientific Misconduct Check	86183-CrossCheck.png
Scientific Editor Work List	86183-Scientific editor work list.pdf